Home LiteratureArticle Details
PMID: 16172378 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation.

Oseroff C, Kos F, Bui HH, Peters B, Pasquetto V, Glenn J, Palmore T, Sidney J, Tscharke DC, Bennink JR, Southwood S, Grey HM, Yewdell JW, Sette A

Abstract

We have analyzed by ex vivo ELISPOT the anti-vaccinia cytotoxic T lymphocyte responses of peripheral blood mononuclear cells from humans vaccinated with Dryvax vaccine. More than 6,000 peptides from 258 putative vaccinia ORFs predicted to bind the common molecules of the HLA A1, A2, A3, A24, B7, and B44 supertypes were screened with peripheral blood mononuclear cells of 31 vaccinees. A total of 48 epitopes derived from 35 different vaccinia antigens were identified, some of which (B8R, D1R, D5R, C10L, C19L, C7L, F12, and O1L) were recognized by multiple donors and contain multiple epitopes recognized in the context of different HLA types. The antigens recognized tend to be >100 residues in length and are expressed predominantly in the early phases of infection, although some late antigens were also recognized. Viral genome regulation and virulence factor were recognized most frequently, whereas few structural proteins were immunogenic. Finally, most epitopes were highly conserved among vaccinia virus Western Reserve, variola major and modified vaccinia Ankara, supporting their potential use in vaccine and diagnostic applications.

MeSH Terms
Amino Acid Sequence Antigens, Viral/immunology Epitopes, T-Lymphocyte/analysis Gene Expression Regulation, Viral Genes, Viral/genetics HLA Antigens/metabolism Histocompatibility Antigens Class I/metabolism Humans Molecular Sequence Data Peptides/blood,genetics,metabolism Smallpox/prevention & control Smallpox Vaccine/immunology,therapeutic use T-Lymphocytes, Cytotoxic/immunology Vaccination Vaccinia/immunology,virology Vaccinia virus/genetics,immunology,pathogenicity Viral Proteins/genetics,immunology,metabolism Virulence/genetics
Chemicals
Antigens, Viral DryVax vaccine Epitopes, T-Lymphocyte HLA Antigens Histocompatibility Antigens Class I Peptides Smallpox Vaccine Viral Proteins
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Oseroff Carla
La Jolla Institute for Allergy and Immunology, 3030 Bunker Hill Street, Suite 326, San Diego, CA 92109, USA.
Kos Ferdynand
Bui Huynh-Hoa
Peters Bjoern
Pasquetto Valerie
Glenn Jean
Palmore Tara
Sidney John
Tscharke David C
Bennink Jack R
Southwood Scott
Grey Howard M
Yewdell Jonathan W
Sette Alessandro
References (29)
29 references, click to expand
  1. Genome-wide analysis of vaccinia virus protein-protein interactions.
    Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4879-84 PMID: 10781095
  2. Using a baculovirus display library to identify MHC class I mimotopes.
    Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2476-81 PMID: 15699351
  3. Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide.
    J Exp Med. 2001 Sep 17;194(6):833-46 PMID: 11560998
  4. Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules.
    Hum Immunol. 2001 Nov;62(11):1200-16 PMID: 11704282
  5. Modeling potential responses to smallpox as a bioterrorist weapon.
    Emerg Infect Dis. 2001 Nov-Dec;7(6):959-69 PMID: 11747722
  6. Transmission potential of smallpox in contemporary populations.
    Nature. 2001 Dec 13;414(6865):748-51 PMID: 11742399
  7. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.
    J Immunol Methods. 2002 Feb 1;260(1-2):157-72 PMID: 11792386
  8. Shining light on "Dark Winter".
    Clin Infect Dis. 2002 Apr 1;34(7):972-83 PMID: 11880964
  9. Immune response to poxvirus infections in various animals.
    Crit Rev Microbiol. 2002;28(3):149-85 PMID: 12385498
  10. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.
    Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):217-22 PMID: 12518065
  11. Quantitating protein synthesis, degradation, and endogenous antigen processing.
    Immunity. 2003 Mar;18(3):343-54 PMID: 12648452
  12. Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses.
    J Exp Med. 2003 Apr 7;197(7):927-32 PMID: 12668642
  13. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism.
    Immunogenetics. 1999 Nov;50(3-4):201-12 PMID: 10602880
  14. Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.
    Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9458-63 PMID: 12869693
  15. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.
    Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9952-7 PMID: 12886016
  16. Constitutive display of cryptic translation products by MHC class I molecules.
    Science. 2003 Sep 5;301(5638):1367-71 PMID: 12958358
  17. Immune recognition of a human renal cancer antigen through post-translational protein splicing.
    Nature. 2004 Jan 15;427(6971):252-6 PMID: 14724640
  18. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
    J Virol. 2004 Jul;78(13):7052-60 PMID: 15194781
  19. Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma.
    Clin Cancer Res. 2004 Aug 15;10(16):5381-90 PMID: 15328176
  20. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.
    Eur J Immunol. 1986 Dec;16(12):1479-87 PMID: 3493144
  21. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes.
    Science. 1988 Feb 5;239(4840):637-40 PMID: 3257585
  22. Structural model of HLA-DR1 restricted T cell antigen recognition.
    Cell. 1988 Feb 26;52(4):515-23 PMID: 2963699
  23. Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes.
    J Gen Virol. 1995 Sep;76 ( Pt 9):2393-8 PMID: 7561783
  24. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
    J Immunol. 1996 Dec 15;157(12):5543-54 PMID: 8955205
  25. Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes.
    J Immunol. 1996 Dec 15;157(12):5555-62 PMID: 8955206
  26. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine.
    Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3183-8 PMID: 9096367
  27. The looming threat of bioterrorism.
    Science. 1999 Feb 26;283(5406):1279-82 PMID: 10037590
  28. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines.
    J Exp Med. 2005 Jan 3;201(1):95-104 PMID: 15623576
  29. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells.
    J Immunol. 2001 Apr 15;166(8):5250-7 PMID: 11290810
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2005-09-27
Epub
2005-00-19
Pages
13980-5
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC1236582
Subset
IM
Grants
NIAID NIH HHS · R01 AI056268 · United States
NIAID NIH HHS · R01-AI-56268 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]